Interestingly, high serum exosomal P-glycoprotein levels are associated with resistance to docetaxel, but not to cabazitaxel, thus representing a potential biomarker for guiding the decision-making process of PCa patients [82]. This evidence concerns the gene ABCB1 and posterior cortical atrophy.